Tissue Testing Technologies LLC

United States of America

Back to Profile

1-15 of 15 for Tissue Testing Technologies LLC Sort by
Query
Aggregations
Jurisdiction
        United States 8
        World 7
Date
2025 December 1
2025 1
2023 4
2022 4
2021 2
See more
IPC Class
A01N 1/02 - Preservation of living parts 11
A01N 1/125 - Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators 1
A01N 59/16 - Heavy metalsCompounds thereof 1
A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof 1
B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers 1
See more
Status
Pending 6
Registered / In Force 9
Found results for  patents

1.

ICE-FREE VITRIFICATION AND NANO-WARMING OF LARGE TISSUE SAMPLES

      
Application Number 19310608
Status Pending
Filing Date 2025-08-26
First Publication Date 2025-12-11
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Brockbank, Kelvin Gm
  • Chen, Zhen Zhen

Abstract

Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one mNP and then subjecting the cellular material to a vitrification preservation protocol including nanowarming. This preservation method is particularly effective for cartilage tissues.

IPC Classes  ?

  • A01N 1/125 - Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators

2.

PRESERVATION OF NATURAL AND BIONENGINEERED TISSUES AND METHODS OF STORING AND TRANSPORT

      
Application Number US2022049930
Publication Number 2023/086664
Status In Force
Filing Date 2022-11-15
Publication Date 2023-05-19
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Campbell, Lia H.
  • Brockbank, Kelvin G.M.

Abstract

Described herein are methods for preserving biomaterials by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods. Also described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample).

IPC Classes  ?

3.

CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES

      
Application Number US2022049939
Publication Number 2023/086668
Status In Force
Filing Date 2022-11-15
Publication Date 2023-05-19
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Campbell, Lia H.
  • Wright, Gregory J.
  • Greene, Elizabeth
  • Brockbank, Kelvin G.M.

Abstract

Described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample) by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods.

IPC Classes  ?

  • C12M 1/32 - Inoculator or sampler multiple field or continuous type
  • C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
  • C12M 1/12 - Apparatus for enzymology or microbiology with sterilisation, filtration, or dialysis means

4.

CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES

      
Application Number 17987257
Status Pending
Filing Date 2022-11-15
First Publication Date 2023-05-18
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Campbell, Lia H.
  • Wright, Gregory J.
  • Greene, Elizabeth
  • Brockbank, Kelvin G.M.

Abstract

Described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample) by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods.

IPC Classes  ?

  • B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
  • B01L 9/00 - Supporting devicesHolding devices

5.

PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES AND METHODS OF STORING AND TRANSPORT

      
Application Number 17987404
Status Pending
Filing Date 2022-11-15
First Publication Date 2023-05-18
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Campbell, Lia H.
  • Brockbank, Kelvin G.M.

Abstract

Described herein are methods for preserving biomaterials by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods. Also described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample).

IPC Classes  ?

6.

PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL

      
Application Number US2022027248
Publication Number 2022/235552
Status In Force
Filing Date 2022-05-02
Publication Date 2022-11-10
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Brockbank, Kelvin G.M.
  • Campbell, Lia H.

Abstract

Cellular material containing living cells is preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing an effective amount of trehalose (in the absence of DMSO and/or any other added cryoprotectants) during a cryopreservation protocol. That is, the cryopreservation protocol is free of cryoprotectant other than trehalose, and the cryopreservation protocol includes: exposing the cellular material to a cryoprotectant formulation containing an effective amount of the trehalose to act as a cryoprotectant, cooling the cellular material at a cooling rate in the range of from ‑3°C/minute to -50°C/minute to a predetermined temperature below -20°C, and obtaining a cryopreserved cellular material that has been warmed.

IPC Classes  ?

7.

PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL

      
Application Number 17731616
Status Pending
Filing Date 2022-04-28
First Publication Date 2022-11-10
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Brockbank, Kelvin G.M.
  • Campbell, Lia H.

Abstract

Cellular material containing living cells is preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing an effective amount of trehalose (in the absence of DMSO and/or any other added cryoprotectants) during a cryopreservation protocol. That is, the cryopreservation protocol is free of cryoprotectant other than trehalose, and the cryopreservation protocol includes: exposing the cellular material to a cryoprotectant formulation containing an effective amount of the trehalose to act as a cryoprotectant, cooling the cellular material at a cooling rate in the range of from −3° C./minute to −50° C./minute to a predetermined temperature below −20° C., and obtaining a cryopreserved cellular material that has been warmed.

IPC Classes  ?

8.

MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES

      
Application Number US2021055788
Publication Number 2022/087089
Status In Force
Filing Date 2021-10-20
Publication Date 2022-04-28
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor Brockbank, Kelvin Gm

Abstract

A method for preserving and reducing the immunogenicity of a tissue, the method including obtaining a first tissue, the first tissue being a wild type tissue or genetically modified tissue; forming a second tissue by immersing the first tissue in a first solution having a cryoprotectant concentration of at least about 75% by weight for at least one hour to kill and lyse the cells of the first tissue; forming a third tissue by removing residual cell materials of the second tissue, the residual cell materials of the second tissue being removed by subjecting the second tissue to decellularization in a bioreactor; and subjecting the third tissue to ice-free cryopreservation.

IPC Classes  ?

  • A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof

9.

MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES

      
Application Number 17506140
Status Pending
Filing Date 2021-10-20
First Publication Date 2022-04-21
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor Brockbank, Kelvin Gm

Abstract

A method for preserving and reducing the immunogenicity of a tissue, the method including obtaining a first tissue, the first tissue being a wild type tissue or genetically modified tissue; forming a second tissue by immersing the first tissue in a first solution having a cryoprotectant concentration of at least about 75% by weight for at least one hour to kill and lyse the cells of the first tissue; forming a third tissue by removing residual cell materials of the second tissue, the residual cell materials of the second tissue being removed by subjecting the second tissue to decellularization in a bioreactor; and subjecting the third tissue to ice-free cryopreservation.

IPC Classes  ?

10.

ICE-FREE VITRIFICATION AND NANO-WARMING OF LARGE TISSUE SAMPLES

      
Application Number US2020058843
Publication Number 2021/091984
Status In Force
Filing Date 2020-11-04
Publication Date 2021-05-14
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Brockbank, Kelvin Gm
  • Chen, Zhen Zhen

Abstract

Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one mNP and then subjecting the cellular material to a vitrification preservation protocol including nanowarming. This preservation method is particularly effective for cartilage tissues and large blood vessels, and includes, for example, exposing the cellular material to a high concentration cryoprotectant formulation containing at least 0.5 mg/mL Fe mNPs, subjecting the cellular material to a preservation protocol in which ice-induced damage to the cellular material does not occur, and obtaining a cryopreserved cellular material that has been nanowarmed; wherein metabolic activity of the nanowarmed tissue is fully recovered to control values within two days of being rewarmed.

IPC Classes  ?

11.

ICE-FREE VITRIFICATION AND NANO WARMING OF LARGE TISSUE SAMPLES

      
Application Number 17088860
Status Pending
Filing Date 2020-11-04
First Publication Date 2021-05-13
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Brockbank, Kelvin Gm
  • Chen, Zhen Zhen

Abstract

Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one mNP and then subjecting the cellular material to a vitrification preservation protocol including nanowarming. This preservation method is particularly effective for cartilage tissues.

IPC Classes  ?

12.

Ice-free preservation of large volume tissue samples for viable, functional tissue banking

      
Application Number 15843462
Grant Number 11246308
Status In Force
Filing Date 2017-12-15
First Publication Date 2018-07-12
Grant Date 2022-02-15
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Brockbank, Kelvin Gm
  • Campbell, Lia H.

Abstract

Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one sugar and then subjecting the cellular material to a vitrification preservation protocol.

IPC Classes  ?

13.

ICE-FREE PRESERVATION OF LARGE VOLUME TISSUE SAMPLES FOR VIABLE, FUNCTIONAL TISSUE BANKING

      
Application Number US2017067060
Publication Number 2018/118799
Status In Force
Filing Date 2017-12-18
Publication Date 2018-06-28
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Brockbank, Kelvin, Gm.
  • Campbell, Lia, H.

Abstract

Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one sugar and then subjecting the cellular material to a vitrification preservation protocol.

IPC Classes  ?

14.

ENHANCEMENT OF CELL CRYOPRESERVATION WITH GLYCOLIPIDS

      
Application Number US2017043090
Publication Number 2018/017843
Status In Force
Filing Date 2017-07-20
Publication Date 2018-01-25
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Campbell, Lia H.
  • Brockbank, Kelvin G. M.

Abstract

The application relates to a method for preserving living cellular material, comprising: exposing a cellular material to medium containing at least one glycolipid and a cryoprotectant for a predetermined amount of time; and after the exposure, subjecting the cellular material to a preservation protocol comprising cryopreservation at a cryopreservation temperature of about -80°C or less.

IPC Classes  ?

15.

Enhancement of cell cryopreservation with glycolipids

      
Application Number 15655381
Grant Number 10687525
Status In Force
Filing Date 2017-07-20
First Publication Date 2018-01-25
Grant Date 2020-06-23
Owner TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventor
  • Campbell, Lia H.
  • Brockbank, Kelvin G M

Abstract

Living cellular material may be preserved by incubating the cellular material in a culture medium containing at least one glycolipid, and then subjecting the cellular material to a preservation protocol.

IPC Classes  ?

  • A01N 1/02 - Preservation of living parts
  • C07H 15/06 - Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of a saccharide radical being a hydroxyalkyl group esterified by a fatty acid